AB InBev (Jefferies) | Vlaamse Federatie van Beleggers
Hele tekst
(2) .
(3) .
(4) ! "
(5) #$#
(6) #%". ( ) *+. #.
(7)
(8)
(9)
(10) !" #
(11) # $%&'()#*'+)#,'+)"- ('&)#.'()#/'/) 012 ')#+')#.')3' 45 6&'( " - 6'&( 012 6&'.3' %7 89. 8"8 :&'& 012 :'&& , :'.&3
(12) ;< 8"8 :'& 0122 :('&& - :'.&3'=87
(13) - 9 >98 7" "8!
(14) 7$%!8"
(15) - 2 "88?887 >7=#
(16) 78 2- 7 "
(17) 7887 7 !!7 8 7827=. 8" 2
(18)
(19) 7 9 ? ' 599
(20) 7' : /"#%; 1 /%#";< 86 /7#&;2< /0#=; 1 /'#%;<86/=#&;2#:->?/$#=;@=<&=!1 /3#3;@=<$0%<86/'#!; @=<='=2+* <* 6A **66 #-B@"#!%<%";+ @7#"%186@"#!'2#@2 7 >'(2 7
(21) 8 7 "- ' ; !8
(22) - -=
(23) ! ' 172 * +* * 6 6 . <+*C + 6 # 1%2D+* 6* 6* #1&2 &#$;< E @&". < E @7"". #102> E %0;%';#1=2 E @0 @0#= # =
(24) 7A7 8B 03
(25) 87 8"8 C+**+C . * 1 &#'" 7#!"2+*C6* * * <** C* + #F * * 6 * #>** + 6 6 1E 2 @0 # FC6 ->? %"%"&#!E# 0(3 D ?
(26) ?
(27) 78 8! =
(28) 7= ! 7=C &G /$#$; + * 6/0#=;1%G/7"#7; 7G/$#3;2#D /'#0;1%G /0#7;<7G7#&;2<B /=#$;1%G/3#7;<7G/7%#&;2< 7"#';1/%7#3;<%=#7;2# 03E5 8!" 9'H &GI I->?"#=;I/7#0;I%#%;186 ";I/%#";I%#";< "#7;I/7#3;I/"#7;2#B>+ 7#=;1%G2. B>F"#=;1%G=#7;2#J C* ="1%G&=2+*3"* 6J*
(29) # */%#";1%G/%#7;2# =
(30) 7A 77 8B 03 E5 0-(+) 2 > 2873 =8!= - 99 87 > C
(31) B ->? 700 **BDA#>*+. * +*
(32) B # 0(3%7 7- 7'&G ** @7<$!$1 @7<$%"<86@7<!"=2 . *6. E @$=31 @'"$<86@$="2#H<* ** 6* 1@'7'2 *# 03 > 28798-J-->?"#3; /7%#=;#F E 1B#6 2< *E1H 2# 2 --
(33) C%
(34) KI3 ->#+++# # F
(35)
(36) 78 C >* %"73- - 7$#3E !; * 73#0E LL '#"; 0#3;#:>6 !"* . %"E %"73-#.
(37) , -. /001"2%"$"%3!0$' 4566#.
(38)
(39)
(40) , -. . /001"2%"$"%3!37&*. 4566#. ,866 9. Please see analyst certifications, important disclosure information, and information regarding the status of non-US analysts on pages 3 to 6 of this report.. &'()& &)%*&')+&.
(41) .
(42) !"#"" $%#&'(.
(43) ABI BB Company Update 25 October 2018 Exhibit 1: ABI – 3Q18 Actual vs Company Compiled Consensus vs Jefferies Volumes (thousand hl) % organic growth Revenue % organic growth Normalized EBITDA % organic growth Normalized EBIT % organic growth Non-recurring items above EBIT Net Finance Costs Non-Recurring Finance Costs Share of Results of Associates Normalised Tax Expense Normalized Effective Tax Rate Profit for the period * attributable to equity holders of ABI * attributable to NCI Normalized Profit to ABI Holders Weighted Average # of Shares Normalized EPS Dividends Per Share (in EUR) Net Debt Net Debt/EBITDA Volume (thousand hl) North America % organic growth Latin America West % organic growth Latin America North % organic growth Latin America South % organic growth EMEA % organic growth Asia Pacific % organic growth GEHC AB InBev % organic growth. 2017 3Q18 2018E 2019E Actual Jeff Cons Actual Act vs cons Jeff Cons Diff Jeff Cons 612,571 149,110 149,512 146,187 -2.2% 573,628 575,315 -0.3% 574,515 581,440 0.2% 1.3% 2.0% 0.2% 0.7% 1.0% 0.6% 1.4% 56,444 13,744 13,972 13,282 -4.9% 54,766 54,995 -0.4% 54,719 55,628 5.1% 5.3% 6.2% 4.5% 5.0% 5.3% 5.0% 5.1% 22,084 5,565 5,742 5,358 -6.7% 22,124 22,541 -1.8% 22,338 23,292 13.4% 6.8% 9.9% 7.5% 6.9% 8.6% 6.3% 7.2% 17,814 4,559 4,762 4,308 -9.5% 17,932 18,314 -2.1% 18,144 19,124 16.5% 6.8% 10.5% 7.1% 7.6% 9.5% 6.5% 7.5% (662) (80) (75) (55) (300) (346) (200) (150) (5,814) (1,805) (1,720) (1,787) 3.9% (5,868) (5,619) 4.4% (4,312) (4,368) (693) (20) (225) (595) (450) (795) 430 90 90 32 321 404 372 424 (2,748) (771) (775) (650) -16.2% (3,137) (3,156) -0.6% (3,320) (3,530) 22.9% 28.0% 24.6% 25.3% 26.0% 25.5% 24.0% 24.2% 9,183 2,001 2,021 1,254 8,523 8,891 10,596 11,374 7,996 1,618 1,667 956 6,831 7,366 -7.3% 8,965 9,900 1,187 383 364 299 1,692 1,462 15.7% 1,630 1,523 2,020 1,614 -20.1% 7,556 8,450 -10.6% 9,254 10,048 7,967 1,690 1,975 1,975 1,974 1,974 1,974 1,975 1,971 1,974 4.04 0.86 1.02 0.82 -20.3% 3.83 4.25 -10.0% 4.69 5.10 3.60 2.00 3.60 3.60 2.00 104,390 4.7x. 100,121 103,004 4.5x 4.6x. 2017 3Q18 Actual Jeff Cons Actual Act vs cons Jeff 113,496 30,109 30,109 29,985 -0.4% 110,659 -0.1% -0.5% -2.5% -3.3% 0.0% 110,625 28,712 28,852 28,462 -1.4% 115,603 1.6% 2.5% 3.0% 1.6% 4.5% 119,374 27,664 28,363 27,204 -4.1% 116,987 1.5% -2.5% -2.0% -0.3% -1.0% 34,062 7,811 7,967 7,444 -6.6% 34,914 2.0% -5.1% 2.5% 5.9% 0.0% 131,692 22,853 22,689 21,803 -3.9% 90,238 2.9% 4.1% 1.3% 0.9% 3.0% 101,986 31,658 31,813 31,290 -1.6% 104,026 2.5% 0.8% 2.0% 0.5% 2.0% 1,336 304 306 -100.0% 1,202 -2.2% 573,628 612,571 149,110 149,512 146,187 2.0% 0.2% -1.8% 0.7% 0.2% 1.3%. 2018E Cons 110,540 -2.7% 116,157 4.9% 117,879 -1.1% 35,274 3.5% 89,698 1.2% 104,556 2.5% 1,184 575,315 1.0%. 95,151 4.3x. 99,974 4.2x. Diff Jeff 0.1% 108,445 -2.0% -0.5% 120,227 4.0% -0.8% 115,817 -1.0% -1.0% 35,263 1.0% 0.6% 88,992 1.5% -0.5% 104,546 0.5% 1.6% 1,225 -0.3% 574,515 0.6%. 2019E Cons 108,548 -2.0% 119,834 3.0% 119,717 2.0% 35,957 1.0% 89,849 2.0% 106,618 2.0% 1,229 581,440 1.4%. Revenue North America % organic growth Latin America West % organic growth Latin America North % organic growth Latin America South % organic growth EMEA % organic growth Asia Pacific % organic growth GEHC AB InBev % organic growth. Actual 15,588 -1.8% 9,238 7.5% 9,775 6.1% 3,363 26.1% 10,344 6.3% 7,804 7.5% 332 56,444 5.1%. Jeff 4,182 2.0% 2,511 7.5% 1,921 3.0% 613 23.0% 2,153 4.0% 2,279 5.5% 84 13,744 5.3%. Cons 4,186 1.9% 2,509 7.5% 1,974 7.5% 616 23.0% 2,231 5.7% 2,292 6.0% 83 13,972 6.2%. Actual Act vs cons 4,162 -0.6% 1.4% 2,472 -1.5% 6.3% 1,960 -0.7% 3.7% 175 -71.6% 13.8% 2,095 -6.1% 4.8% 2,310 0.8% 5.2% 107 28.9% 13,282 -4.9% 4.5% -1.7%. Jeff 15,523 -0.5% 10,135 9.5% 9,030 4.5% 2,884 24.0% 8,532 2.8% 8,318 5.0% 346 54,766 5.0%. Cons 15,510 -0.7% 10,098 9.5% 9,119 5.8% 3,032 22.9% 8,532 4.2% 8,396 6.0% 355 54,995 5.3%. Diff 0.1%. Normalized EBITDA North America % organic growth Latin America West % organic growth Latin America North % organic growth Latin America South % organic growth EMEA % organic growth Asia Pacific % organic growth GEHC AB InBev % organic growth. Actual 6,329 1.3% 4,512 16.0% 4,180 4.5% 1,595 20.1% 3,349 17.9% 2,695 31.2% (577) 22,084 13.4%. Jeff 1,681 -2.0% 1,235 11.5% 801 7.0% 313 30.0% 844 4.7% 809 10.1% (122) 5,565 6.8%. Cons 1,715 0.1% 1,273 14.3% 859 13.4% 313 29.4% 891 12.5% 845 14.5% (118) 5,742 9.9%. Actual Act vs cons 1,671 -2.6% -2.2% 1,303 2.4% 17.6% 841 -2.1% 11.6% 72 -77.0% 14.4% 786 -11.8% -0.9% 849 0.4% 14.6% (164) 39.0% 5,358 -6.7% 7.5% -2.4%. Jeff 6,077 -4.0% 5,086 12.6% 4,044 9.5% 1,420 30.0% 3,117 3.5% 2,968 8.2% (589) 22,124 6.9%. Cons Diff 6,145 -1.1% -2.8% 5,134 -0.9% 13.7% 4,095 -1.2% 11.4% 1,437 -1.2% 30.0% 3,249 -4.1% 7.2% 3,030 -2.0% 10.6% (618) -4.8% 22,541 -1.8% 8.6%. 0.4% -1.0% -4.9% 0.0% -0.9% -2.7% -0.4%. Diff -1.2% -1.6% -4.1% -5.1%. -1.3%. -6.0%. -9.4% 7.1% -7.9% -8.1%. Diff -0.1% 0.3% -3.3% -1.9% -1.0% -1.9% -0.3% -1.2%. Jeff 15,503 0.0% 10,795 8.0% 8,792 6.0% 2,679 20.0% 8,281 5.0% 8,309 4.5% 359 54,719 5.0%. Cons Diff 15,521 -0.1% 0.1% 10,685 1.0% 7.0% 9,338 -5.8% 6.6% 3,045 -12.0% 19.5% 8,592 -3.6% 6.0% 8,545 -2.8% 6.0% 365 -1.8% 55,628 -1.6% 5.1%. Jeff 6,069 0.0% 5,485 9.3% 3,938 6.0% 1,320 20.0% 3,087 6.1% 3,033 6.8% (594) 22,338 6.3%. Cons Diff 6,173 -1.7% 0.7% 5,573 -1.6% 9.3% 4,129 -4.6% 7.0% 1,312 0.6% 17.5% 3,351 -7.9% 7.7% 3,181 -4.6% 8.4% (611) -2.7% 23,292 -4.1% 7.2%. Source: Jefferies estimates, company consensus page 2 of 6. Please see important disclosure information on pages 3 - 6 of this report.. Edward Mundy, ACA, Equity Analyst, +44 (0)20 7029 8476, emundy@jefferies.com.
(44) ABI BB Company Update 25 October 2018. 9>
(45) - 8>78 $%$" * + 6*+ M6 #. 9>
(46) F
(47)
(48) 78 #@8 $%$" : !">?L #C72LNI <%2 <&2
(49) BA O#.
(50) 7 7828-
(51) 78 C <- + J <<6 * 6*+E * * 6 + *5 12. 5 12# 6 * 6 + <<+< < *6 +E * *# <- P. <6 * 6*+E * * 6 + *5 12. 5 12# 6 * 6 + <<+< < *6 +E * *# @!87
(52) 78 2 E5
(53)
(54) 7C- + J < 866 9 <
(55) B 66 686699 I. 6 * +*LH#>* 12 686699< LH6<. *6 5*LH%%07 +* 5 < * * # @!87
(56) 78 2 E5
(57)
(58) 7C- P. 866 9 <
(59) B 66 686699 I . 6 * +*LH#>* 12 686699< LH6< *6 . 5*LH%%07 +* 5 < * * # * +* 866 < * 12 6 * 6 * 6. * * 6 6 * 6< C # F C * < 6 # 6 * <* 5 6 * * )5 #. %"797@- 99
(60) 78 @- . 0 78-03
(61) 78-, 2@3 * ?. :%=<%"7!<"%"%-># :%=<%"7!<"%"%->#. 9>
(62) 5>-828-8- 866D99 C C *?6 ** #. G>
(63)
(64) 78 2122 8@
(65) 78! ?* +E 1 267=;+* 7% * # P ?* +E 1 267=; 7";+* 7% * #
(66) 6?* +E 1 26 7";+* 7% * # >*E 1 26 +* +@7"%"; +* 7% * * * * C C# L P +* +@7"<*E 1 2 %";+* 7% * #L
(67) 6 +* +@7"<*E 1 2 %";+* 7% * # H>* * #B* +* I 866# B B #866* 6* # HH #866 * # ?+*< 5 +*866 < * 6 < # J ?+* 6 6. < 6+** 6. 5 * 6* #. F
(68)
(69) 78 7= ! 866) * 6 * 6+ C O < < +*I < E * E7% *#>* * <+** < < 6 C C<+* < < *6+1?L2<->?<-B< *6+1L2<6 *6+1LL2<-QI->?<I-<-I+*<IL<I LL<1 2I -QI->?<1 2I I-<6* < < <. . 1:-2* E7% *# 122 8;
(70) -=848- page 3 of 6. Please see important disclosure information on pages 3 - 6 of this report.. Edward Mundy, ACA, Equity Analyst, +44 (0)20 7029 8476, emundy@jefferies.com.
(71) ABI BB Company Update 25 October 2018 866L *C C 6 *C 6. 7% * #BC. 6 C *6 * < 66 < 6 CI+ ** 866 #866L *C+ C * 6 #BC+ + +* * 6 * <*C* <6 I6 #BC* 7%" . *. 6BAC+ * 7=;< * +* %";#L *C 66C <+ +*+ C6 +* * +* #. @8 =8-=9
(72) 89> 7=
(73) -=8"97 2 4 8-
(74) !7 >*+ 6 6 #*<*6. * 6 C*+ * 6 5 6. O *+ 6. * # 6 6*6. ** C 66#>*< 6< 6<. 6*6. * + 6 66 * <6. 6 #6 6. ** * )* < * E* 66 *6< 6< 6*6. *# < * ?<+* 66 * 6* <66 C#. H 7C- *E * > P * * * +** < * 6 6 # 9 ?? PP
(75)
(76) 6 L ? 6 *< + *II5 # E#I I ?# %7%#%!0#%&""#. 87 8?78 2@
(77) 78! IB Serv./Past 12 Mos.. JIL Mkt Serv./Past 12 Mos.. Rating. Count. Percent. Count. Percent. Count. Percent. BUY HOLD UNDERPERFORM. 1163 814 122. 55.41% 38.78% 5.81%. 94 14 0. 8.08% 1.72% 0.00%. 15 0 0. 1.29% 0.00% 0.00%. page 4 of 6. Please see important disclosure information on pages 3 - 6 of this report.. Edward Mundy, ACA, Equity Analyst, +44 (0)20 7029 8476, emundy@jefferies.com.
(78) ABI BB Company Update 25 October 2018 7= %9> 7
(79) 78- 866 C +* *# < * + * 866 * 66 * 66*5 6*# * * 6 C * # 866 -. * 6 * 6 * 6+ 866 D 99 1R866S2 E87 57
(80) 7C86699+** B- C 6LH1 866 *B<99<. B- < 6* *2# E87 8! 9C866 9 <+** *O *L. * T - . F H#73$!'%7T 66Q <'!
(81) >* B<9 -0Q&8T* /001"2%"$"%3!"""T6 /00 1"2%"$"%3!"7"# ! !C866P K 9 <+** *B L 6P K +*- >B=0'T B%%"7<%% L<* K <%G M <P K # 58!
(82) > C866B 9 <+** *J * 6B T !" 66 U7=%"<
(83) : O %< B "0!'%0<* /'='==7&3="# 1
(84) >
(85) C86618 29 <>C *<+** *L. B 68 6*8 B? T P J <&L<7=7V C*<* C<>C 7"""""'T* /!7&=%=7 '7""T6 /!7&=%=7'7"7# % 8
(86) C866 9 1H
(87) $070"JP%""$>%""="32<+** *B -E* 6 J* C1HJ""""7700&2< * 1HP""""""$"72 BCC+* BC-E* 9 1H"77037"&&2 H BC-E* 6 9 1H%&7037"&$2 * J CB T 0%I0&<%H* <J CJ E < K E< 1- 2J 0"""=7< T>/37%%0&=''"""# >*+ . +* +*8661866 9 <866P K 9 <866B 9 <86618 29 <866 9 2T . +* +**86699 866 * B991R8BS2#86699
(88) B C 66 +*8B<+**
(89) B #8B O * * 8B #6 6* *< 8B#:*+< 86699#86699<8B< * 66 6 + R866S# 866 C +* * *# < * + * 866 * 6 6 * 66*5 6*# * * 6 6 C * #B6 66 * * . LH * 6* * # ,,, 6 *6
(90) B866 < *6+
(91) * * 6 B6*
(92) #B# B673&&< <* *
(93) B 86699<+** 6 . +** 67= ' *
(94) BB-E* 673&0< #> * 66
(95) B. 66 **86699# *
(96) K - - * I 6 . 866 9 1R89S2 6 +* * < * * < 6 E E< +* *+ +6 # 89 + C +C#89M 6 * 89 . 66 * 6* +C#86699<89 * 66 < C C . *6. 6 *T +** C C<* 6 * R 6 S# L <* 6 6 #H 6* * * +* ? 6 *B 1: 2# B <866B 9 1R8B9S2 *J * 6B #L *6 B <* 8B9 &%6*L. #>* * 6 <E < 6 *B L1 #%!36B 2#6* . 6< . +** < 8B9< !" 66 U7=%"<
(97) : O %<B "0!'%0< * /'='==7&3="# 8 <* 86618 29 # P K < * 866P K 9 6 6 6 *P K B L: . # *6* 1> + 2<** #>* * * *M6* 1RS2#>* 66* . 6 66 *# * * * . 6 * * 6 < <6 I 6* **# <* 866 9 # <* 6 89 +* +*. * 6* %""76 1*2< . +** 6 * *56* # 66* *56* .< * < +* * 6*#89 * *L. * * +6*
(98) K <+** 666 +#89* 6 B . : "&I7"33<+** E6* 6. * 6* 6 6. +* # 6* *5 * 6* . . *6* # >* 66 6 66 < C # * )5 6* 6 < 5* +* #866 . * . 6 #866< *66< < < * * < 6*< * * < * 6*+ #>* 6 6 <. < C <* 5<6* < <6. < 6 #*< * 6 #866 6 * 6 * 6 * 6E 5 # 6** C +*6 +** * 6* . * M <6 *+ <C 6 < E #866 page 5 of 6. Please see important disclosure information on pages 3 - 6 of this report.. Edward Mundy, ACA, Equity Analyst, +44 (0)20 7029 8476, emundy@jefferies.com.
(99) ABI BB Company Update 25 October 2018 6 * *C+** * * +* M 5<6* < <6. < *< *8B *866 * < < * 6* M # C * 6*< * 6 *< * M5 C#>* 6**+ +6 #6* *6866991* 66 C 2< . +* * 6 * 56* <*C 6 + 6 * #: 8B +**B- T *6 *86699 . *866 66 * 6 . +* 6*# >* 6 * 6 * * 6 * 6 # 6 6 6 <6 < 6 #L E* * 66. * 6< 6< # >** 6 6 * 6 6#H-. * . * * +* C + * 66*12# *. *6*866 * 666*+6*866 # >* 6 6* < 6 * B AM# . 6* 6* E+**+ 6* * #866 * < < 6 6 < < 6 1 *+2< 6* <6* 6*6* #>* E + < < < + 6* 6 6 #H*866 . * * 6 < < <E < < < . < <E < 6<1 6 2 . +* 6* < # 6 66 * <* #>* * 6* 66 < * # 866 * < < < 6#- * #>* *6 < +**+ 6866# H*866 6 <66 < 6 *6. 6 < +* 6 < . 6 6* #H* * * + 866*
(100) #B#6 +# L ? 6 8B< *II 6##I?I I I W W*# EX PWQBHW?Y0!&!$! *II 6##ILI%3%70% + *II5 # E#I I ?# <+++#566#< 7#!!!#8-LL--B# Z%"7!866D99. page 6 of 6. Please see important disclosure information on pages 3 - 6 of this report.. Edward Mundy, ACA, Equity Analyst, +44 (0)20 7029 8476, emundy@jefferies.com.
(101)
GERELATEERDE DOCUMENTEN
Voor 2019 wordt een sterke omzet- en EBITDA-groei verwacht, onder meer omdat de kosten minder zullen stijgen dan de inflatie.. Verder streeft het naar een meer evenwichtige
[r]
BUY
BUY
Registration of non-US analysts: Peter Welford, CFA is employed by Jefferies International Limited, a non-US affiliate of Jefferies LLC and is not registered/qualified as a
De groep keek tegen een bescheiden daling van de volumes aan, maar slaagde er dankzij de bijdrage van de premium merken en de hogere verkoopprijzen in om de
Registration of non-US analysts: Peter Welford, CFA is employed by Jefferies International Limited, a non-US affiliate of Jefferies LLC and is not registered/qualified as a
Jefferies International Limited has implemented policies to (i) address conflicts of interest related to the preparation, content and distribution of research reports,